3 completed, 3 terminated, 1 active not recruiting. 7 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Terminated 3, Active not recruiting 1 |
| Phase 1 | 4 | Completed 3, Active not recruiting 1 |
Follow Recurrent Anaplastic Large Cell Lymphoma: new trials by email Literature Review of Recurrent Anaplastic Large Cell Lymphoma trials Research Report on Recurrent Anaplastic Large Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas Anti-CD30/CD16A Monoclonal Antibody AFM13, Cyclophosphamide, Fludarabine - Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 45 | 2020-07-18 | 2026-09-30 |
| Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas Pembrolizumab, Pralatrexate - Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype | Phase 1 / Phase 2 | Active not recruiting | City of Hope Medical Center | 13 | 2019-02-25 | 2026-10-29 |
| Study of Pembrolizumab (MK-3475) in Combination With Romidepsin Pembrolizumab, Romidepsin - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 38 | 2017-11-14 | 2026-11-16 |
| Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Laboratory Biomarker Analysis, Nivolumab - Blastic Plasmacytoid Dendritic Cell Neoplasm, Hepatosplenic T-Cell Lymphoma | Phase 2 | Terminated | Mayo Clinic | 12 | 2017-05-17 | 2020-04-21 |
| Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL Onalespib - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 25 | 2016-04-04 | 2022-09-13 |
| Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 46 | 2010-05-19 | 2023-01-23 |
| Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cytarabine - Anaplastic Large Cell Lymphoma, ALK-Negative, Recurrent Anaplastic Large Cell Lymphoma | Phase 1 / Phase 2 | Completed | University of Nebraska | 74 | 2009-11-12 | 2023-10-10 |
Lymphoma, Large-Cell, Anaplastic (7) · Lymphoma, T-Cell (4) · Mycosis Fungoides (4) · Immunoblastic Lymphadenopathy (3) · Lymphoma, Mantle-Cell (3) · Enteropathy-Associated T-Cell Lymphoma (2) · Lymphoma, Follicular (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Burkitt Lymphoma (1) · HTLV-I Infections (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1)
Hemic and Lymphatic Diseases (7) · Immune System Diseases (7) · Immunoproliferative Disorders (7) · Lymphatic Diseases (7) · Lymphoma (7) · Lymphoproliferative Disorders (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Lymphoma, Non-Hodgkin (6) · Lymphadenopathy (3) · Lymphoma, T-Cell (3) · Lymphoma, T-Cell, Cutaneous (3) · Hematologic Diseases (2) · Infections (2) · Leukemia (2)
Cyclophosphamide (2) · fludarabine phosphate (2) · pembrolizumab (2) · (2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone (1) · 10-propargyl-10-deazaaminopterin (1) · AFM13 (1) · CT-P10 (1) · Carmustine (1) · Cytarabine (1) · Depsipeptides (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Lactones (1) · Lenalidomide (1)
M.D. Anderson Cancer Center (2) · City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · University of Nebraska (1)
United States (7)
Alex F Herrera (1) · Caron A Jacobson (1) · Julie Vose, MD, MBA (1) · Rachel B. Salit (1) · Stephen Ansell (1) · Swaminathan P Iyer, MD (1) · Yago L Nieto (1)
PMID 23834234, PMID 35750419, PMID 40186077
P30CA015083 (1), P30CA036727 (1), UM1CA186690 (1), UM1CA186709 (1)